Ribbon Adds $100M Equity Line, $1M Note, and 4.1M-Share Forward Purchase Ahead of DRC Merger
RIBB is trading near its 52-week low of $9.95 (9.0% above the low) on elevated volume (18× avg).
Summary
Ribbon disclosed a multi-part financing package with Meteora — a $100M equity line, a $1M convertible note, and a forward purchase agreement for up to 4.1M shares — all contingent on the DRC Medicine merger closing, with highly dilutive variable-rate conversion terms.
Key Events · Financing and Capital Events · RIBB
-
Forward Purchase Agreement for 4.1M Shares
Meteora agreed to purchase up to 4,100,000 PubCo shares post-merger at the redemption price, with a $10.00 reference price that resets weekly to the lower of $10.00 or the prior week's VWAP.
-
Variable-Rate Convertible Note
The $1,212,121 note (17.5% OID, $1M net proceeds) converts at the lower of a fixed price or 95% of the lowest daily VWAP over the preceding 5 trading days, with a 7% payment premium and 18% default interest.
-
9.9% Share Escrow as Collateral
Upon merger closing, shareholders will deposit 9.9% of PubCo's outstanding shares into escrow; on a Note default, title transfers to Meteora as partial liquidated damages.
-
Right of First Refusal on Future Financings
Meteora holds a six-month right to invest up to 33% of any future debt, equity, or derivative financing, excluding future equity lines of credit.
Analysis · RIBB · Real Estate & Construction
A complex, highly dilutive financing package has been layered onto Ribbon Acquisition Corp.'s pending DRC Medicine merger. Beyond the previously disclosed $100M standby equity purchase agreement and $1M convertible note, this filing reveals a forward purchase agreement covering up to 4.1 million shares, a subscription agreement for the same, an escrow of 9.9% of post-merger shares as collateral, and a right of first refusal on 33% of future financings. The convertible note converts at 95% of the lowest VWAP over five days — a variable-rate structure that can accelerate dilution as the stock falls. Against a backdrop of a going-concern warning, a $1.8M working capital deficit, and a trust account depleted to $38.4M after massive redemptions, these terms signal that Ribbon is paying a steep price for survival capital. The financing is contingent on the business combination closing, which remains subject to shareholder approval.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.7% of the 583 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RIBB was trading at $10.85 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $68M. The 52-week trading range was $9.95 to $10.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.